Announce Date | 03/31/2025 |
EPS Normalized Actual | $-1.28 (Miss by $-0.08) |
EPS GAAP Actual | $-1.28 (Miss by $-0.08) |
Revenue Actual | $0.131297B |
Revenue Surprise | Beat by $131.297M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0 |
EPS GAAP Estimate | $0 |
Revenue Estimate | $0.132962214B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 4.2 | 0.57 | 3.86519 | 4.6035 | 0 |
Dec 2026 | 4.2 | 0.57 | 4.10439 | 4.30316 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -6.67 | -6.67 | 0.131297B | -81.8% | -36.62M |
FQ1 2025 (Mar 2025) | -0.09 | -0.09 | 0.165815B | 100% | 165.82M |
FQ4 2024 (Dec 2024) | -2.46 | -2.503333 | 0.148817B | 100% | -145.75M |
FQ3 2024 (Sep 2024) | -1.37 | -1.36 | 0.213465B | 100% | -90.94M |
FQ2 2024 (Jun 2024) | -3.08 | -3.2925 | 0.238694B | 100% | -78.04M |
FQ1 2016 (Feb 2016) | -0.0705 | -0.0705 | 0B | NAN% | 0M |
FQ2 2016 (May 2016) | -0.0515 | -0.0515 | 0B | NAN% | 0M |
FQ3 2016 (Aug 2016) | -0.0461 | -0.0461 | 0B | NAN% | 0M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.132962214B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | 0 | INF | 0 | 0 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | 0.13B | -60.55 | 0.13B | 0.13B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
1
Revenue # of Misses
4
Revenue # of in-lines
3
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -6.67 | -6.67 | 100% |
FQ1 2025 (Mar 2025) | -0.09 | -0.09 | 100% | |
FQ4 2024 (Dec 2024) | 0.043333 | -2.46 | -2.503333 | 101.76% |
FQ3 2024 (Sep 2024) | -0.01 | -1.37 | -1.36 | 99.27% |
FQ2 2024 (Jun 2024) | 0.2125 | -3.08 | -3.2925 | 106.9% |
FQ1 2016 (Feb 2016) | -0.0705 | -0.0705 | 100% | |
FQ2 2016 (May 2016) | -0.0515 | -0.0515 | 100% | |
FQ3 2016 (Aug 2016) | -0.0461 | -0.0461 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.17B | $0.13B | $-36.62M | -27.89% |
FQ1 2025 (Mar 2025) | $0B | $0.17B | $165.82M | 100% |
FQ4 2024 (Dec 2024) | $0.29B | $0.15B | $-145.75M | -97.94% |
FQ3 2024 (Sep 2024) | $0.3B | $0.21B | $-90.94M | -42.6% |
FQ2 2024 (Jun 2024) | $0.32B | $0.24B | $-78.04M | -32.7% |
FQ1 2016 (Feb 2016) | $0B | $0B | $0M | NAN% |
FQ2 2016 (May 2016) | $0B | $0B | $0M | NAN% |
FQ3 2016 (Aug 2016) | $0B | $0B | $0M | NAN% |